[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-396363-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-396363-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","chst-infliximab-remicade-or-biosimilar-infusion-therapy-plan-neurology","CHST Infliximab (Remicade or Biosimilar) - Infusion Therapy Plan (Neurology)","","CHST infliximab infusion therapy plan (neurology) for children, specifying baseline demographics and required orders across the full treatment course. The plan covers therapy duration review at least annually, admit and nursing orders including hypotension thresholds and TB screening, and pregnancy testing requirements for females over 10 with instructions to withhold infusion if positive. It lists IV access guidance, topical lidocaine options for procedural comfort, pre-procedure laboratory intervals, and acetaminophen pre-medicating instructions, with a key of medical abbreviations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/chst-infliximab-remicade-or-biosimilar-infusion-therapy-plan-neurology/396363/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/chst-infliximab-remicade-or-biosimilar-infusion-therapy-plan-neurology/396363.png","ImageObject",300,407,{"name":42,"@type":43},"Marglet","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-26",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How is hypotension defined before starting infliximab infusion?","Question",{"text":63,"@type":64},"Hypotension is defined using age-based systolic blood pressure thresholds (e.g., 1 month to 1 year: SBP \u003C 70; 11 to 17 years: SBP \u003C 90) or a drop of more than 30% from baseline. Baseline SBP times 0.7 indicates the hypotension cutoff value.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What are the pregnancy test requirements before infusion for female patients over 10?",{"text":68,"@type":64},"Only one pregnancy test is needed based on facility capability. A urine, STAT, one-time pregnancy test is required for females > 10 years old; if positive, do NOT infuse and contact the ordering provider.",{"name":70,"@type":61,"acceptedAnswer":71},"Which pre-procedure labs and pre-medications are specified in the plan?",{"text":72,"@type":64},"Pre-procedure labs include CBC with differential and hepatic function panel, both with intervals every 12 weeks and deferred until after the 3rd infusion, then every 3 months. Acetaminophen is given 30 minutes prior (suspension or tablet, 15 mg/kg max 650 mg), with instruction to administer only one formulation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},396363,1790718888,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},2336477982702,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","*PHYO*  \nPHYO  \nCMC85137-002NS Rev. 11/2021  \nCHILDREN'S HEALTH Page 1 of 6  \nPatient Name:  \nDate of Birth:  \nCHST INFLIXIMAB  \n(REMICADE or BIOSIMILAR)  \nINFUSION THERAPY PLAN (NEUROLOGY)  \nBaseline Patient Demographic  \nTo be completed by the ordering provider.  \nDiagnosis:    \n NKDA-No Known Drug Allergies   \nHeight:   cm Weight:   kg Body Surface Area:   (m2)  \nAllergies:    \nTherapy Plan orders extend over time (several visits) including recurring treatment.  \nPlease specify the following regarding the entire course of therapy:  \nDuration of treatment:   weeks   months   unknown  \nTreatment should begin:  as soon as possible (within a week)  within the month  \n**Plans must be reviewed / re-ordered at least annually. **  \nORDERS TO BE COMPLETED FOR EACH THERAPY  \nADMIT ORDERS  \n􀀹 Height and weight  \n~~􀀹~~ Vital signs  \nHYPOTENSION DEFINED ADMIT  \n~~􀀹~~ Nursing communication  \nPrior to starting infusion, please determine the patient's threshold for hypotension as defined by the following parameters. This information will be needed in the event of an infusion reaction.  \nHypotension is defined as follows:  \n1 month to 1 year-systolic blood pressure (SBP) less than 70  \n1 year to 11 years-systolic blood pressure (SBP) less than 70 + (2 x age in years)  \n11 years to 17 years-systolic blood pressure (SBP) less than 90  \nOR any age-systolic blood pressure (SBP) drop of more than 30% from baseline.  \nBaseline systolic blood pressure (SBP) x 0.7 = value below defined as hypotension.  \nPREGNANCY TESTS AT DALLAS AND PLANO  \nNursing communication  \nOnly one pregnancy test is necessary, based on facility capabilities. Please utilize the lab that is available per facility.  \nPatient requires a pregnancy test (based on organizational policy, female patients over 10 require a pregnancy test) Pregnancy test, urine-POC  \nSTAT, ONE TIME, for females > 10 years old. If positive, do NOT infuse and contact the ordering provider. Gonodotropin chorionic (HCG) urine  \nSTAT, ONE TIME, unit collect, for females > 10 years old. If positive, do NOT infuse and contact the ordering provider.  \nNURSING ORDERS  \n􀀹 Nursing communication  \nConfirm TB test is negative within last year, if no test or positive, contact ordering provider.  \nIV START NURSING ORDERS  \n~~􀀹~~ Insert peripheral IV / Access IVAD  \nPlace PIV if needed or access IVAD if available  \n lidocaine 1% BUFFERED (J-TIP LIDOCAINE)  \n0.2 mL, INTRADERMAL, PRN  \n when immediate procedure needed  when procedure will take about 1 minute  patient / family preference for procedure Administration Instructions: NOTE: Do not use this medication in patients with bleeding disorders, platelets \u003C 20,000, or in patients taking anticoagulants, when accessing implanted ports or using a vein that will be utilized for chemotherapy administration, nor for pre-term infants or neonates.  \nKey: cm = centimeter; HCG = Gonodotropin chorionic; IV = intravenous; IVAD = implantable venous access device; kg = kilogram; m² = square meters; mg = milligram; mL = milliliter; mL / hr = milliliters per hour; mOsm / L = milliosmole per liter; NKDA = no known drug allergies; pH = hydrogen ion concentration; PIV = peripheral intravenous; POC = point of care; PRN = as needed; RTA= ready to administer; STAT = immediately; TB = tuberculosis  \n*PHYO*  \nPHYO  \nCMC85137-002NS Rev. 11/2021  \nCHILDREN'S HEALTH  \nPatient Name:  \nDate of Birth:  \nCHST INFLIXIMAB  \n(REMICADE or BIOSIMILAR) INFUSION THERAPY PLAN (NEUROLOGY)  \nPage 2 of 6  \nORDERS TO BE COMPLETED FOR EACH THERAPY  \nNURSING ORDERS, CONTINUED  \nPlease select all appropriate therapy  \n lidocaine-prilocaine (EMLA) cream  \nTOPICAL, PRN  \n when more than 60 minutes are available before procedure  when procedure will take more than 1 hour  patient / family preference for procedure  \nAdministration Instructions: NOTE: In children \u003C 3 months of age, or \u003C 5 kg in weight, maximum application time is 1 hour.  lidocaine-tetracaine (SYNERA) patch  \nTOPICAL, PRN  \n when 20-30 minutes are av","cbCaiqcuxW4Och9k","https://ap.wps.com/l/cbCaiqcuxW4Och9k","pdf",290221,"English","# Baseline and Therapy Course Instructions\n## Orders for Each Therapy (Admit, Nursing, IV Start)\n# Hypotension Definition and Nursing Communication\n## Pregnancy Testing Requirements\n# Nursing Orders (Continued)\n## Topical Anesthesia Options\n# Pre-Procedure Labs\n# Pre-Medications","[{\"question\":\"How is hypotension defined before starting infliximab infusion?\",\"answer\":\"Hypotension is defined using age-based systolic blood pressure thresholds (e.g., 1 month to 1 year: SBP \\u003c 70; 11 to 17 years: SBP \\u003c 90) or a drop of more than 30% from baseline. Baseline SBP times 0.7 indicates the hypotension cutoff value.\"},{\"question\":\"What are the pregnancy test requirements before infusion for female patients over 10?\",\"answer\":\"Only one pregnancy test is needed based on facility capability. A urine, STAT, one-time pregnancy test is required for females \\u003e 10 years old; if positive, do NOT infuse and contact the ordering provider.\"},{\"question\":\"Which pre-procedure labs and pre-medications are specified in the plan?\",\"answer\":\"Pre-procedure labs include CBC with differential and hepatic function panel, both with intervals every 12 weeks and deferred until after the 3rd infusion, then every 3 months. Acetaminophen is given 30 minutes prior (suspension or tablet, 15 mg/kg max 650 mg), with instruction to administer only one formulation.\"}]","CHST Infliximab (Remicade or Biosimilar) - Infusion Therapy Plan (Neurology) | PDF",1790439940,15]